"Partners:
Both have been having talks with large pharmas. anp are certainly being noticed and are probably ahead on this score"
-----
Unless a commercial partner offers a crazy very sweet deal there is absolutely no need for NEU to license NNZ-2566 given the DoD is 99.999% guaranteed to fund half of the Phase III trial and NDA application costs.
All without taking a cent from future non-military sales.
neu v anp, page-2
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.86 |
Change
-0.160(1.23%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $13.06 | $13.26 | $12.81 | $2.258M | 174.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 66 | $12.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.86 | 1023 | 17 |
View Market Depth
| Last trade - 12.46pm 15/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |